A Phase I Trial of AT13387 in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) Receiving Concurrent Radiation and Cisplatin

Trial Profile

A Phase I Trial of AT13387 in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) Receiving Concurrent Radiation and Cisplatin

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 12 May 2017

At a glance

  • Drugs Cisplatin (Primary) ; Onalespib (Primary)
  • Indications Head and neck cancer; Human papillomavirus infections; Squamous cell cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 02 Jun 2016 Status changed from active, no longer recruiting to recruiting.
    • 01 Jun 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top